TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
IRMD

Iradimed Co

Healthcare · Medical Devices

85.20$ -1.3% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Balance Sheet

Iradimed Co (IRMD) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 115 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios
Annual Quarterly
Amounts Change % Common size %
Last 12 Full history
Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet IRMD
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
35 37 37 37 38 39 40 43 47 48 54 57 63 67 68 69 70 71 72 76 78 83 72 76 80 86 76 81 87 92 88 90 94 98 102 106 115 109 114 115
33 34 34 33 33 35 36 39 43 45 47 50 56 59 61 60 63 64 65 69 72 76 66 68 72 77 61 66 72 76 72 74 74 75 75 77 85 81 86 87
16 18 17 17 18 18 20 21 24 28 30 32 39 43 45 45 48 50 51 55 58 62 50 52 56 58 43 46 47 50 45 49 52 52 50 53 57 51 56 59
24 26 25 24 25 26 28 30 31 34 35 38 43 46 47 48 50 52 53 56 59 63 51 52 56 58 43 46 47 50 45 49 52 52 50 53 57 51 56 59
4.5 3.8 3.7 3.8 3.5 3.8 3.3 4.0 5.2 4.2 5.3 5.9 6.9 7.3 5.9 4.5 4.3 4.6 4.6 3.9 4.3 5.1 6.5 8.4 11 13 12 11 13 12 13 12 10 11 13 11 14 14 13 13
3.5 3.9 4.3 4.3 4.1 4.2 4.3 4.4 4.3 4.1 4.2 4.4 4.4 3.6 4.2 4.9 4.6 3.9 4.6 4.5 4.4 4.3 4.3 4.9 5.2 5.4 6.3 8.4 12 13 13 12 11 10 11 11 12 12 12 12
1.3 1.5 1.6 1.7 1.9 1.9 1.9 1.9 1.9 1.9 1.9 1.8 2.0 2.1 2.1 2.2 2.2 2.1 2.1 4.7 4.7 4.6 4.6 4.6 2.3 2.4 8.6 8.7 – – – – – – – – – – – –
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – –
0.8 0.9 0.9 0.9 0.9 0.9 0.9 0.8 0.8 0.8 0.8 0.8 0.8 0.9 0.9 0.9 1.0 1.0 1.0 1.0 1.1 1.1 1.3 1.5 1.9 2.1 2.2 2.4 2.5 2.5 2.7 2.7 2.9 3.1 3.3 3.4 3.4 3.4 3.3 3.4
4.8 5.3 5.4 5.5 5.8 6.1 6.0 6.7 6.7 6.5 9.8 9.7 11 11 10 10 9.7 9.7 9.1 11 11 11 9.8 9.8 9.8 12 11 12 13 21 12 10 11 12 12 12 16 14 16 13
3.4 3.7 3.6 3.6 3.9 4.1 3.9 4.6 4.8 4.7 5.0 4.9 5.7 5.9 4.9 5.3 4.8 4.9 4.6 6.3 6.3 6.8 6.2 6.1 5.6 8.6 6.8 7.6 7.9 16 7.6 7.5 8.1 8.5 8.5 8.8 13 10 12 9.2
1.5 1.4 1.6 1.2 1.6 1.7 1.6 1.9 1.9 2.0 0.2 0.2 0.2 0.2 0.2 0.2 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.4 0.4 0.4 0.4 0.4 0.4 0.3 0.2 0.1 – – – – –
1.0 1.1 0.9 0.7 0.8 0.7 0.7 0.7 1.0 0.8 1.2 1.0 1.2 1.0 0.9 0.7 0.6 0.7 0.6 0.7 0.8 0.8 1.1 0.8 1.0 1.8 1.8 2.6 2.8 1.9 1.3 1.1 1.4 1.9 2.6 1.9 2.3 1.8 2.2 1.8
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 – 2.9 – – – – – – – – – – – – – – – – – – – – – – – – – – – – –
31 32 32 31 32 33 34 36 40 42 45 47 52 56 58 58 61 61 63 65 68 72 63 66 70 74 64 69 75 71 76 80 83 87 90 94 98 95 99 102
19 20 20 20 20 20 21 23 25 27 29 31 33 36 38 36 37 38 39 41 43 47 37 40 44 47 37 42 47 43 47 50 54 57 59 63 66 64 67 70
12 12 11 12 12 12 12 12 12 12 12 12 12 12 12 12 12 13 13 13 13 13 13 13 13 13 13 13 13 13 13 13 13 13 13 13 13 13 13 13

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?